Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
13:32:21 02/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 11.52 HKD | +4.82% |
|
-0.69% | -3.76% |
| 10:41am | Roche, Simcere Pharma Strike Drug Licensing Deal | DJ |
| 09-01 | Roche signs global licensing pact for Simcere's experimental blood cancer drug | RE |
| Market Cap | 3.6B 28.22B 3.11B 2.92B 2.66B 5B 342B 5.03B 34.53B 13.44B 174B 13.52B 13.22B 576B | P/E 2026 * |
13.7x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 3.4B 26.68B 2.93B 2.76B 2.52B 4.73B 323B 4.76B 32.64B 12.7B 164B 12.77B 12.5B 545B | EV / Sales 2026 * |
2.27x | EV / Sales 2027 * | 2.04x |
| Free-Float |
32.13% | Yield 2026 * |
3.83% | Yield 2027 * | 4.34% |
| 1 day | +4.82% | ||
| 1 week | -0.69% | ||
| Current month | +3.78% | ||
| 1 month | -5.50% | ||
| 3 months | +15.32% | ||
| 6 months | -2.62% | ||
| Current year | -3.76% |
| 1 week | 10.96 |  | 11.65 |
| 1 month | 10.96 | | 12.82 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.55 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/8/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/7/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/7/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.82% | -0.69% | -11.45% | +85.51% | 3.6B | |
| -0.04% | +1.54% | +23.23% | +73.94% | 48.77B | |
| -1.09% | +0.25% | +52.39% | +119.54% | 40.67B | |
| -1.16% | +0.37% | +15.87% | +86.01% | 12.27B | |
| -0.77% | +0.66% | -10.02% | +13.98% | 12.11B | |
| +0.57% | +1.73% | +31.59% | +153.11% | 9.28B | |
| -0.15% | -1.87% | +25.21% | +46.24% | 7.55B | |
| -1.85% | -0.54% | +26.39% | +218.48% | 7.35B | |
| -0.16% | -0.38% | +45.37% | -10.85% | 7.3B | |
| -0.13% | -0.16% | -40.47% | +15.85% | 5.25B | |
| Average | +0.01% | +0.47% | +15.81% | +80.18% | 15.42B | |
| Weighted average by Cap. | -0.40% | +1.11% | +26.54% | +86.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 11.77B 1.29B 1.22B 1.11B 2.09B 142B 2.1B 14.4B 5.6B 72.47B 5.64B 5.51B 240B | 1.69B 13.27B 1.46B 1.37B 1.25B 2.35B 161B 2.36B 16.23B 6.32B 81.69B 6.35B 6.21B 271B |
| Net income | 255M 2B 220M 207M 189M 355M 24.22B 357M 2.45B 953M 12.32B 958M 938M 40.86B | 302M 2.37B 260M 245M 223M 419M 28.63B 422M 2.89B 1.13B 14.56B 1.13B 1.11B 48.29B |
| Net Debt | -197M -1.55B -170M -160M -146M -274M -18.73B -276M -1.89B -737M -9.53B -741M -725M -31.58B | -140M -1.1B -121M -113M -103M -194M -13.26B -195M -1.34B -522M -6.75B -525M -513M -22.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | HK$11.52 | +4.82% | 8,356,000 |
| 01/09/26 | HK$10.99 | -0.99% | 4,355,000 |
| 31/08/26 | HK$11.10 | -1.77% | 7,703,000 |
| 28/08/26 | HK$11.30 | -1.82% | 4,726,000 |
| 27/08/26 | HK$11.51 | -0.78% | 4,617,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
